Researchers are excited about this new drug, a novel dual agonist showing remarkable results in early trials for weight management. It works by impacting both systems: GLP-1 and GIP, which , when https://deannaacgo206594.dsiblogger.com/73831415/the-new-possibility-for-body-loss